BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15322712)

  • 1. [Perspectives and limitations in the treatment of vagus-induced atrial fibrillation. Insights from cellular pharmacology].
    Brandts B; Van Bracht M; Dirkmann D; Borchard R; Wickenbrock I; Prull MW; Meine M; Trappe HJ
    Med Klin (Munich); 2004 Jul; 99(7):341-6. PubMed ID: 15322712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibition of the muscarinic potassium current by KB130015, a new antiarrhythmic agent to treat atrial fibrillation].
    Borchard R; van Bracht M; Wickenbrock I; Prull MW; Pott L; Trappe HJ
    Med Klin (Munich); 2005 Nov; 100(11):697-703. PubMed ID: 16328176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of I
    Juhász V; Hornyik T; Benák A; Nagy N; Husti Z; Pap R; Sághy L; Virág L; Varró A; Baczkó I
    Can J Physiol Pharmacol; 2018 Jan; 96(1):18-25. PubMed ID: 28892643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of IK,ACh current may contribute to clinical efficacy of class I and class III antiarrhythmic drugs in patients with atrial fibrillation.
    Voigt N; Rozmaritsa N; Trausch A; Zimniak T; Christ T; Wettwer E; Matschke K; Dobrev D; Ravens U
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Mar; 381(3):251-9. PubMed ID: 19760273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticholinergic effects of class III antiarrhythmic drugs in guinea pig atrial cells. Different molecular mechanisms.
    Mori K; Hara Y; Saito T; Masuda Y; Nakaya H
    Circulation; 1995 Jun; 91(11):2834-43. PubMed ID: 7758191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New antiarrhythmic agents in atrial fibrillation].
    Hernández GP; Ortíz PL; López FA; Mondragón Ldel V
    Arch Cardiol Mex; 2007; 77 Suppl 2():S2-59-S2-63. PubMed ID: 17972381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat.
    Blaauw Y; Gögelein H; Tieleman RG; van Hunnik A; Schotten U; Allessie MA
    Circulation; 2004 Sep; 110(13):1717-24. PubMed ID: 15364815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a highly selective acetylcholine-activated K+ channel blocker on experimental atrial fibrillation.
    Machida T; Hashimoto N; Kuwahara I; Ogino Y; Matsuura J; Yamamoto W; Itano Y; Zamma A; Matsumoto R; Kamon J; Kobayashi T; Ishiwata N; Yamashita T; Ogura T; Nakaya H
    Circ Arrhythm Electrophysiol; 2011 Feb; 4(1):94-102. PubMed ID: 21156770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial-selective antiarrhythmic actions of novel Ikur vs. Ikr, Iks, and IKAch class Ic drugs and beta blockers in pigs.
    Knobloch K; Brendel J; Rosenstein B; Bleich M; Busch AE; Wirth KJ
    Med Sci Monit; 2004 Jul; 10(7):BR221-8. PubMed ID: 15232496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol inhibits IK(Ado) by competitive A1-receptor interaction.
    Brandts B; Dirkmann D; Borchard R; Wickenbrock I; Van Bracht M; Prull MW; Trappe HJ
    Z Kardiol; 2004 Jul; 93(7):533-9. PubMed ID: 15243764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SD-3212, a new class I and IV antiarrhythmic drug: a potent inhibitor of the muscarinic acetylcholine-receptor-operated potassium current in guinea-pig atrial cells.
    Hara Y; Nakaya H
    Br J Pharmacol; 1995 Nov; 116(6):2750-6. PubMed ID: 8591000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects on atrial repolarization of the interaction between K+ channel blockers and muscarinic receptor stimulation.
    Zaza A; Malfatto G; Schwartz PJ
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1095-104. PubMed ID: 7791080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the selective KACh channel blocker NTC-801 on atrial fibrillation in a canine model of atrial tachypacing: comparison with class Ic and III drugs.
    Yamamoto W; Hashimoto N; Matsuura J; Machida T; Ogino Y; Kobayashi T; Yamanaka Y; Ishiwata N; Yamashita T; Tanimoto K; Miyoshi S; Fukuda K; Nakaya H; Ogawa S
    J Cardiovasc Pharmacol; 2014 May; 63(5):421-7. PubMed ID: 24805146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of aprindine on the delayed rectifier K+ current and the muscarinic acetylcholine receptor-operated K+ current in guinea-pig atrial cells.
    Ohmoto-Sekine Y; Uemura H; Tamagawa M; Nakaya H
    Br J Pharmacol; 1999 Feb; 126(3):751-61. PubMed ID: 10188988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide.
    Knobloch K; Brendel J; Peukert S; Rosenstein B; Busch AE; Wirth KJ
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):482-7. PubMed ID: 12382079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of muscarinic potassium current by the class III antiarrhythmic drug RP58866 in guinea-pig atrial myocytes.
    Brandts B; Van Bracht M; Tüttelmann F; Allessie MA; Trappe HJ
    Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1812-5. PubMed ID: 11139931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of dofetilide in patients with atrial fibrillation. Insights from the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) study.
    Singh SN
    Card Electrophysiol Rev; 2003 Sep; 7(3):225-8. PubMed ID: 14739718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of in vivo and in vitro electrophysiological and antiarrhythmic effects of a novel IKACh blocker, NIP-151: a comparison with an IKr-blocker dofetilide.
    Hashimoto N; Yamashita T; Tsuruzoe N
    J Cardiovasc Pharmacol; 2008 Feb; 51(2):162-9. PubMed ID: 18287884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of KCB-328, a new IKr blocking antiarrhythmic agent in pacing induced canine atrial fibrillation.
    Chandra P; Rosen TS; Yeom ZH; Lee K; Kim HY; Danilo P; Rosen MR
    Europace; 2004 Sep; 6(5):384-91. PubMed ID: 15294262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histamine H1-receptor-mediated modulation of the delayed rectifier K+ current in guinea-pig atrial cells: opposite effects on IKs and IKr.
    Matsumoto Y; Ogura T; Uemura H; Saito T; Masuda Y; Nakaya H
    Br J Pharmacol; 1999 Dec; 128(7):1545-53. PubMed ID: 10602335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.